- Integration of CiNii Books functions for fiscal year 2025 has completed
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- Start the collection of all publicly IRDB content
- Incorporate Research Data from KAKEN
Lignans from the Bark of Machilus thunbergii and Their DNA Topoisomerases I and II Inhibition and Cytotoxicity
-
- Li Gao
- College of Pharmacy, Yeungnam University College of Pharmacy, Yanbian University
-
- Lee Chong-Soon
- Department of Biochemistry, College of Science, Yeungnam University
-
- Woo Mi-Hee
- College of Pharmacy, Catholic University of Daegu
-
- Lee Seung-Ho
- College of Pharmacy, Yeungnam University
-
- Chang Hyeun-Wook
- College of Pharmacy, Yeungnam University
-
- Son Jong-Keun
- College of Pharmacy, Yeungnam University
Bibliographic Information
- Other Title
-
- Lignans from the Bark of Machilus thunbergii and Their DNA Topoisomerases 1 and 2 Inhibition and Cytotoxicity
- Published
- 2004
- Resource Type
- journal article
- DOI
-
- 10.1248/bpb.27.1147
- Publisher
- The Pharmaceutical Society of Japan
Search this article
Description
Activity-guided fractionation based on topoisomerase I inhibitory activity lead to the isolation of ten lignans (1—10) from the methylene chloride extract of the bark of Machilus thunbergii SIEB. et ZUCC. (Lauraceae). These were identified as machilin A (1), erythro-austrobailignan-6 (2), meso-monomethyl dihydroguaiaretic acid (3), meso-dihydroguaiaretic acid (4), galbacin (5), machilin F (6), nectandrin A (7) nectandrin B (8), (−)-acuminatin (9) and (7S,8S)-7-(4-hydroxy-3-methoxyphenyl)-1′-formyl-3′-methoxy-8-methyldihydrobenzofuran (10) by spectral evidence. In DNA topoisomerase I and II assays in vitro at a concentration of 100 μM, 4 showed the most potent inhibitory activity, 93.6 and 82.1% inhibition, respectively, and 8 showed 79.1 and 34.3% inhibition, respectively. All of these compounds exhibited weak or no cytotoxicities against either the human colon carcinoma cell line (HT-29) or the human breast carcinoma cell line (MCF-7).
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 27 (7), 1147-1150, 2004
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679603855744
-
- NII Article ID
- 110003608932
-
- NII Book ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 6986971
-
- PubMed
- 15256759
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed